Filing Details
Alto Neuroscience, Inc. (NYSE:ANRO) filed a Form 8-K with the Securities and Exchange Commission on July 14, 2026, disclosing a material event.
8k filedNYSE:ANRO
Alto Neuroscience, Inc. (ANRO) Reports Material Event to SEC
Filing Details Alto Neuroscience, Inc. (NYSE:ANRO) filed a Form 8-K with the Securities and Exchange Commission on July 14, 2026, disclosing a material event. Market Context Alto…
Market Context
Alto Neuroscience, Inc.'s stock currently trades at $27.80 with a market capitalization of $611.7M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Alto Neuroscience, Inc.'s stock.
All SEC filings for Alto Neuroscience, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ANRO Stock Page
Frequently Asked Questions
Where can I read ANRO's SEC filings?
Browse all filings on our ANRO SEC filings page.
What types of SEC filings does Alto Neuroscience, Inc. file?
Public companies like Alto Neuroscience, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.